Atlas Trials

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

Clinical trial NCT04115007 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04115007
Sponsor
UNICANCER
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Oligometastatic Hormone Sensitive Prostate Cancer
Start date
2020-06-23
Primary completion
2026-06-23
Enrollment
550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.